For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2026 before the market opens on ...

Earlier this week, Labcorp announced the nationwide availability of ColoSense, the first FDA-approved RNA-based at-home ...

LH expands specialty testing, acquisitions and AI initiatives to drive growth, but macro pressures and currency headwinds ...

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

Patients who get blood work through Labcorp can now receive AI-generated plain-language explanations of their results inside ...

The nationwide rollout, which Labcorp disclosed Monday, comes weeks after the Centers for Medicare and Medicaid Services approved coverage for ColoSense, and the American Cancer Society named the test ...

Shares of Labcorp Holdings Inc. LH rallied 1.39% to $283.88 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.22% to 7,483 ...

Detailed price information for Laboratory Corp of America (LH-N) from The Globe and Mail including charting and trades.

The AI juggernaut is all-in on the healthcare industry, launching three new products in the last six months. But it needs to ...

Labcorp OnDemand enables convenient testing with the NASHnext® test, within a physician-directed care pathway to support identification of patients with at-risk MASH This model expands access and ...